Owner of SPP and PharmSolv, and is an advanced drug delivery systems industry leader. Dr. Harland has worked in the field of pharmaceutical product development and with advanced drug delivery systems for over 20 years where he has developed more than 75 products. Dr. Harland has started and grown 2 international drug delivery companies, PharmSolv and Gattec.

Mr. Mills orchestrated the $1.4 Billion acquisition of Qualitest Rx by Endo Pharmaceutical in 2010 as CEO of Qualitest Rx. He previously ran Columbia Laboratories as President and Chief Executive Officer, and more than quadrupling the value of Columbia Laboratories. Mr. Mills has over 30 years of professional experience at the executive management level in corporate direction and operations with both branded and major generic companies.

Dr. Lewis has directed the analytical laboratories at Genzyme Corporation in Farmingham, Massachusetts. Dr. Lewis has over 25 years of experience in analytical research, quality control and quality assurance. Prior to Genzyme, he was the Vice President of Quality Control for Ivax Corporation (now Teva Pharmaceutical Ltd.).

Owner of SPP and PharmSolv, and is an advanced drug delivery systems industry leader. Dr. Harland has worked in the field of pharmaceutical product development and with advanced drug delivery systems for over 20 years where he has developed more than 75 products. Dr. Harland has started and grown 2 international drug delivery companies, PharmSolv and Gattec.